Wakix ইউরোপীয় ইউনিয়ন - লাত্‌ভীয় - EMA (European Medicines Agency)

wakix

bioprojet pharma - pitolisant - narkolepsija - other nervous system drugs - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.

Crysvita ইউরোপীয় ইউনিয়ন - লাত্‌ভীয় - EMA (European Medicines Agency)

crysvita

kyowa kirin holdings b.v. - burosumabs - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - zāles kaulu slimību ārstēšanai - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Metoclopramid Polpharma 10 mg/2 ml šķīdums injekcijām লাত্ভিয়া - লাত্‌ভীয় - Zāļu valsts aģentūra

metoclopramid polpharma 10 mg/2 ml šķīdums injekcijām

pharmaceutical works polpharma sa, poland - metoklopramīda hidrohlorīds - Šķīdums injekcijām - 10 mg/2 ml